Canopy Slaps GW With Patent Suit Over Flagship CBD Drug

Canopy Slaps GW With Patent Suit Over Flagship CBD Drug Canadian cannabis company Canopy Growth is accusing GW Pharmaceuticals of ripping off its patented CBD extraction technology to make the flagship CBD drug Epidiolex. #CBD #Hemp https://www.law360.com/cannabis/articles/1340452?utm_source=rss&utm_medium=rss&utm_campaign=section December 23, 2020 1:28 pm